• Synonyms：
  Maleimide-PEG-Amine
  
• Purity：
  ≥95%
• Recommended Storage Condition：
  Store at -5°C,keep in dry and avoid sunlight.
• Uses：
  Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Maleimide-PEG-Amine (Mal-PEG-NH2) is a linear heterobifunctional PEG linker that is generally employed as crosslinking agents or as spacers between two different chemical entities.

Cited Publications

This PEG derivative has been cited in peer-reviewed scientific publications. Browse the references below to learn more.

1. ​Lee, J. R., Kim, Y. M., Kim, E. J., Jang, M. K., & Park, S. C. (2024). Advancing Breast Cancer Therapeutics: Targeted Gene Delivery Systems Unveiling the Potential of Estrogen Receptor-Targeting Ligands. Biomaterials research, 28, 0087. https://doi.org/10.34133/bmr.0087 
2. Moura, R. P., Carvalho, E. D., Martins, C., Des Rieux, A., Pêgo, A. P., & Sarmento, B. (2023). Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders. Journal of Controlled Release, 358, 43-58. https://doi.org/10.1016/j.jconrel.2023.04.034  
3. Kim, J., Kim, J. S., Min, K. H., Kim, Y., & Chen, X. (2021). Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery. Bioengineering, 8(4), 43. https://doi.org/10.3390/bioengineering8040043 
4. Lourenço, B. N., Pereira, R. F., Barrias, C. C., Fischbach, C., Oliveira, C., & Granja, P. L. (2021). Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells. Nanomaterials, 11(2), 295. https://doi.org/10.3390/nano11020295 
5. Martins, C., Araújo, F., Gomes, M. J., Fernandes, C., Nunes, R., Li, W., Santos, H. A., Borges, F., & Sarmento, B. (2019). Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy. European Journal of Pharmaceutics and Biopharmaceutics, 138, 111-124. https://doi.org/10.1016/j.ejpb.2018.01.014

View more publications citing Biopharma PEG products.